1. Yao, Yufeng, Liu, Nannan, Zhou, Ziyun, Shi, Li. 2019. Influence of ERAP1 and ERAP2 gene polymorphisms on disease susceptibility in different populations. In Human immunology, 80, 325-334. doi:10.1016/j.humimm.2019.02.011. https://pubmed.ncbi.nlm.nih.gov/30797823/
2. Ma, Yubo, Fan, Dazhi, Xu, Shanshan, Zhang, Xu, Pan, Faming. 2021. Ankylosing Spondylitis Patients Display Aberrant ERAP1 Gene DNA Methylation and Expression. In Immunological investigations, 51, 1548-1560. doi:10.1080/08820139.2021.1982965. https://pubmed.ncbi.nlm.nih.gov/34555981/
3. Kronborg, Lasse, Hansen, Emma Oxlund, Bertelsen, Trine, Iversen, Lars, Johansen, Claus. . ERAP1 and ERAP2 gene variants as potential clinical biomarkers of anti-interleukin-17A response in psoriasis vulgaris. In Clinical and experimental dermatology, 49, 1171-1178. doi:10.1093/ced/llae128. https://pubmed.ncbi.nlm.nih.gov/38616723/
4. Tempora, Patrizia, D'Amico, Silvia, Gragera, Paula, Locatelli, Franco, Fruci, Doriana. 2024. Combining ERAP1 silencing and entinostat therapy to overcome resistance to cancer immunotherapy in neuroblastoma. In Journal of experimental & clinical cancer research : CR, 43, 292. doi:10.1186/s13046-024-03180-y. https://pubmed.ncbi.nlm.nih.gov/39438988/
5. Wu, Xiujuan, Zhao, Zongfeng. 2021. Associations between ERAP1 Gene Polymorphisms and Psoriasis Susceptibility: A Meta-Analysis of Case-Control Studies. In BioMed research international, 2021, 5515868. doi:10.1155/2021/5515868. https://pubmed.ncbi.nlm.nih.gov/34395615/
智鼠故事 
